Is 5-Amino-1MQ a peptide?
No. It is a small-molecule research compound.
A small-molecule NNMT research inhibitor. It is classified as a Research Compound, not under Peptides.
Research material
5-Amino-1MQ is a small-molecule research compound rather than a peptide. It is commonly investigated in studies involving nicotinamide N-methyltransferase (NNMT), an enzyme that participates in methyl-group and nicotinamide metabolism. This distinction matters: unlike peptide research materials, 5-Amino-1MQ is evaluated as a low-molecular-weight chemical probe for enzyme-focused experiments. Researchers use NNMT-associated models to explore how enzyme activity may relate to cellular methylation balance, NAD+-linked metabolism, and adipocyte or cancer-cell biology. The compound’s appropriate use is within qualified laboratory research, with experimental conclusions limited to the methods and models employed.
Select Volume
Live CAD price
$59.99
Selected size
5-Amino-1MQ 10MGQuantity
For research purposes only. Not for human or veterinary use.
Free shipping on orders over $250 CAD
Multi-unit savings: 3 units — 10% off · 5 units — 15% off · 10 units — 20% off. Promotional savings are subject to confirmation at checkout.
A small-molecule NNMT research inhibitor. It is classified as a Research Compound, not under Peptides.
Materials are intended strictly for laboratory and analytical research.
Contact research support5-Amino-1MQ has been described in research as an NNMT inhibitor. NNMT catalyzes methylation of nicotinamide using S-adenosylmethionine, connecting its activity to methyl-donor utilization and nicotinamide pathways. Inhibitor studies may assess enzymatic activity, substrate turnover, transcriptomic responses, or metabolic-network changes. The relevance of NNMT varies substantially among tissues and model systems, and inhibitor selectivity, concentration, and assay design require direct evaluation. Proposed downstream effects in cells or animals are investigational and should not be portrayed as established outcomes in people.
Evidence is primarily biochemical, cellular, and preclinical. It is a research compound, not a peptide and not a consumer-use product.
No. It is a small-molecule research compound.
It is commonly studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT.
NNMT connects nicotinamide metabolism with methyl-donor handling, making it relevant to several cellular-metabolism models.